Lexicon Pharmaceuticals Inc (LXRX)
1.65
+0.10
(+6.80%)
USD |
NASDAQ |
May 01, 16:00
1.68
+0.03
(+1.82%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Investing (Quarterly): 51.90M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 51.90M |
| September 30, 2023 | -39.33M |
| June 30, 2023 | -74.61M |
| March 31, 2023 | 12.09M |
| December 31, 2022 | 24.17M |
| September 30, 2022 | -77.20M |
| June 30, 2022 | -13.65M |
| March 31, 2022 | -4.408M |
| December 31, 2021 | 6.096M |
| September 30, 2021 | -0.40M |
| June 30, 2021 | 14.14M |
| March 31, 2021 | -17.72M |
| December 31, 2020 | 44.10M |
| September 30, 2020 | 215.80M |
| June 30, 2020 | 78.07M |
| March 31, 2020 | 42.78M |
| December 31, 2019 | -109.40M |
| September 30, 2019 | -31.28M |
| June 30, 2019 | -7.45M |
| March 31, 2019 | -7.726M |
| December 31, 2018 | 58.75M |
| September 30, 2018 | 56.40M |
| June 30, 2018 | 47.37M |
| March 31, 2018 | 7.063M |
| December 31, 2017 | -135.77M |
| Date | Value |
|---|---|
| September 30, 2017 | 87.05M |
| June 30, 2017 | 56.79M |
| March 31, 2017 | 42.46M |
| December 31, 2016 | 56.46M |
| September 30, 2016 | 33.90M |
| June 30, 2016 | 61.54M |
| March 31, 2016 | -133.64M |
| December 31, 2015 | -124.14M |
| September 30, 2015 | 77.77M |
| June 30, 2015 | 0.34M |
| March 31, 2015 | -70.99M |
| December 31, 2014 | -170.72M |
| September 30, 2014 | 20.51M |
| June 30, 2014 | 1.223M |
| March 31, 2014 | 40.57M |
| December 31, 2013 | 39.77M |
| September 30, 2013 | 20.24M |
| June 30, 2013 | 10.43M |
| March 31, 2013 | 29.11M |
| December 31, 2012 | -6.729M |
| September 30, 2012 | 11.64M |
| June 30, 2012 | 26.86M |
| March 31, 2012 | -129.58M |
| December 31, 2011 | 18.03M |
| September 30, 2011 | 30.74M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-109.40M
Minimum
Dec 2019
215.80M
Maximum
Sep 2020
5.985M
Average
-0.40M
Median
Sep 2021
Cash from Investing (Quarterly) Benchmarks
| Windtree Therapeutics Inc | 0.00 |
| Novavax Inc | -9.078M |
| AIM ImmunoTech Inc | -0.214M |
| Protalix BioTherapeutics Inc | -0.342M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.55M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow | -162.37M |
| Free Cash Flow Per Share (Quarterly) | -0.2062 |
| Free Cash Flow to Equity (Quarterly) | -50.79M |
| Free Cash Flow Yield | -44.53% |